278 related articles for article (PubMed ID: 34779163)
21. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
22. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
23. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ
J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort.
Zhu B; Zheng T; Wang W; Gu Y; Wei C; Li Q; Wang Z
J Neurol; 2024 Apr; 271(4):1893-1900. PubMed ID: 38095723
[TBL] [Abstract][Full Text] [Related]
25. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Miettinen MM; Antonescu CR; Fletcher CDM; Kim A; Lazar AJ; Quezado MM; Reilly KM; Stemmer-Rachamimov A; Stewart DR; Viskochil D; Widemann B; Perry A
Hum Pathol; 2017 Sep; 67():1-10. PubMed ID: 28551330
[TBL] [Abstract][Full Text] [Related]
27. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
28. Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience.
Garozzo D
Neurol India; 2019; 67(Supplement):S38-S44. PubMed ID: 30688231
[TBL] [Abstract][Full Text] [Related]
29. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
30. Abdominal neoplastic manifestations of neurofibromatosis type 1.
Dare AJ; Gupta AA; Thipphavong S; Miettinen M; Gladdy RA
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i124-i133. PubMed ID: 32642738
[TBL] [Abstract][Full Text] [Related]
31. French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study.
Wolkenstein P; Chaix Y; Entz Werle N; Amini-Adle M; Barbarot S; Boileau C; Miled A; Rashid T; Aerts I
Eur J Med Genet; 2023 May; 66(5):104734. PubMed ID: 36868501
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromatosis type 1 (NF1) and associated tumors.
Rosenbaum T; Wimmer K
Klin Padiatr; 2014 Nov; 226(6-7):309-15. PubMed ID: 25062113
[TBL] [Abstract][Full Text] [Related]
33. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
34. [Type 1 neurofibromatosis: Onset of two tumors before the age of 5years].
Remillieux M; Durand C; Sartelet H; Piolat C; Bourgeois E; Pommier P; Hameury F; Dieterich K; Vidaud D; Perret C
Arch Pediatr; 2017 Oct; 24(10):986-990. PubMed ID: 28870819
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
[TBL] [Abstract][Full Text] [Related]
36. TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.
Park GH; Lee SJ; Yim H; Han JH; Kim HJ; Sohn YB; Ko JM; Jeong SY
Oncol Rep; 2014 Oct; 32(4):1347-54. PubMed ID: 25109740
[TBL] [Abstract][Full Text] [Related]
37. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
de Blank PMK; Gross AM; Akshintala S; Blakeley JO; Bollag G; Cannon A; Dombi E; Fangusaro J; Gelb BD; Hargrave D; Kim A; Klesse LJ; Loh M; Martin S; Moertel C; Packer R; Payne JM; Rauen KA; Rios JJ; Robison N; Schorry EK; Shannon K; Stevenson DA; Stieglitz E; Ullrich NJ; Walsh KS; Weiss BD; Wolters PL; Yohay K; Yohe ME; Widemann BC; Fisher MJ
Neuro Oncol; 2022 Nov; 24(11):1845-1856. PubMed ID: 35788692
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
39. Surgical Management of "Kissing" Spinal Plexiform Neurofibromas in Neurofibromatosis Type 1 Patients.
Shofty B; Mauda-Havakuk M; Ben-Sira L; Bokstein F; Lidar Z; Salame K; Korn A; Constantini S
World Neurosurg; 2020 Feb; 134():e1143-e1147. PubMed ID: 31786384
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.
Masliah-Planchon J; Pasmant E; Luscan A; Laurendeau I; Ortonne N; Hivelin M; Varin J; Valeyrie-Allanore L; Dumaine V; Lantieri L; Leroy K; Parfait B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
BMC Genomics; 2013 Jul; 14():473. PubMed ID: 23848554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
